It is shown that higher amounts of CSF progranulin are related to higher levels of triggering receptor expressed on myeloid cells 2 (TREM2) in CSF and associated with weaker cognitive performance in patients with late AD. This evidence concerns the gene GRN and Alzheimer disease.